Lecture 13 Flashcards
Describe haemostasis?
It is a physiological process. it stops leakage of blood from injured vessels (by plugging the leaks and sets up the vessel to be repaired). Response of vessels to injury.
Describe the process of haemostasis?
In healthy vessels, haemostasis is actively switched off, however it is ready to go and be of use. Endothelial cells inhibit (actively) haemostasis in a healthy vessel. Endothelial cells physically insulate the tissues underneath them from the blood on top of them. As soon as your blood comes into contact with the tissues underlying the endothelium it initiates haemostasis very rapidly. The endothelial cells produce both chemical and enzymatic inhibitors (NO and prostacyclin).
What happens when a blood vessel becomes injured?
Haemostasis actively and rapidly turns on. It is a cooperation effort between: endothelial cells, platelets and the clotting cascade. The endothelial cells are the initiator of haemostasis.
what do the endothelial cells do?
Normally they prevent haemostasis from being turned on. But when a vessel is injured then the cells switch, and they actively turn on haemostasis. They produce endothelin, a substance which causes vasoconstriction (less blood lost through a damaged vessel and easier time to repair a leak). The underlying tissues are exposed, especially CT proteins which activate platelets and coagulation cascade. Endothelial cells also produce von Willebrand Factor which promotes platelet adhesion to ECM proteins that have been exposed. And they produce a substance called thromboplasitn (which directly activates coagulation cascade).
What do the platelets do?
They are produced by megakaryocytes in the bone marrow (fragment their cytoplasm). They last about a week in the cytoplasm. The alpha and dense granules contain chemical mediators of paltelet activation and activity. Once the platelets become activated, then the alpha and dense granules start to degranulate and secrete substances such as: Thromoxane A2, vasoactive amines, ADP. This allows haemostasis to be turned on rapidly. These substances cause further vasoconstriction and for the platelets to aggregate towards each other.
What happens when a person does not have enough platelets?
There is bleeding from skin capillaries or spontaneous haemorrhage.
Describe the coagulation cascade?
There are several different pathways which can activate this coagulation cascade. It turns on a series of enzymatic cleavage events. This ends up with a fibrin web which stabilises the platelets in a plug. It is a proteolytic cascade (cleaving one another). Once zymogens have been cleaved, this enzyme then cleaves the zymogen below it and so forth. Gradually build up a series of cleavage events.
What initiates the coagulation cascade? and describe the process of the coagulation cascade?
Lots of different factors: tissue factor that is produced when the vessel wall is damaged. The activation of thrombin, which catalyses the conversion of fibrinogen into fibrin monomers which turn into fibrin strands, which stabilise the platelet plug. Thrombin activates and catalyses some of the earlier events in the cascade. So the fibrin strands form a dense network.
When does thrombosis occurs?
When the physiological process of haemostasis are turned on inappropriately.
What is the formal definition of thrombosis?
Mass formed from blood constituents within the circulation during life.
What are thrombi composed of?
Fibrin and platelets with red blood cells trapped in their.
Where can thrombi form?
In both arteries and veins. Thrombi prevent blood form getting to the tissues downstream.
what is an embolus?
When a piece of the thrombus breaks off to obstruct a vessel downstream.
What is a clot?
A clot is formed from static blood and involves the coagulation system. It is jelly like, and it is different to thrombus.
Describe Virchow’s Triad?
There are three things that are predisposing factors for thrombosis:
- Endothelial injury - changes in the vessel wall.
- Hypercoagulability - changes in blood flow.
- Abnormal blood flow - changes in constituents of blood.